Search research articles
Contact Us
Filters
Showing results (311-320 of 328) with videos related to
Page
of 33
Sort By:
Human Molecular Genetics
|
October 11, 2019
Acute manganese treatment restores defective autophagic cargo loading in Huntington's disease cell lines
Miles R Bryan, Michael T O'Brien, Kristen D Nordham, et al.
Sleep
|
November 11, 2020
A potential role for zinc in restless legs syndrome
Pan Chen, Julia Bornhorst, Stephanie Patton, et al.
Neurochemistry International
|
January 24, 2020
The effects of manganese overexposure on brain health
Mahfuzur R Miah, Omamuyovwi M Ijomone, Comfort O A Okoh, et al.
Aging and Disease
|
June 23, 2016
Linear and Curvilinear Trajectories of Cortical Loss with Advancing Age and Disease Duration in Parkinson's Disease
Daniel O Claassen, David G Dobolyi, David A Isaacs, et al.
Biomaterials
|
July 24, 2015
Combinatorial polymer matrices enhance in vitro maturation of human induced pluripotent stem cell-derived cardiomyocytes
Young Wook Chun, Daniel A Balikov, Tromondae K Feaster, et al.
Sensors and Actuators. B, Chemical
|
June 7, 2021
A bistable, multiport valve enables microformulators creating microclinical analyzers that reveal aberrant glutamate metabolism in astrocytes derived from a tuberous sclerosis patient
Dusty R Miller, David K Schaffer, M Diana Neely, et al.
Metallomics : Integrated Biometal Science
|
May 19, 2020
Huntington's disease genotype suppresses global manganese-responsive processes in pre-manifest and manifest YAC128 mice
Anna C Pfalzer, Jordyn M Wilcox, Simona G Codreanu, et al.
Journal of Huntington'S Disease
|
September 4, 2015
Novel BAC Mouse Model of Huntington's Disease with 225 CAG Repeats Exhibits an Early Widespread and Stable Degenerative Phenotype
Michal Wegrzynowicz, Terry Jo Bichell, Barbara D Soares, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
September 18, 2022
Treatment with THI, an inhibitor of sphingosine-1-phosphate lyase, modulates glycosphingolipid metabolism and results therapeutically effective in experimental models of Huntington's disease
Giuseppe Pepe, Luca Capocci, Federico Marracino, et al.
Scientific Reports
|
May 26, 2018
Author Correction: Defective Sphingosine-1-phosphate metabolism is a druggable target in Huntington's disease
Alba Di Pardo, Enrico Amico, Abdul Basit, et al.
Page
of 33
Search research articles
Search
Showing results (311-320 of 328) with videos related to
Sort By:
Page
of 33
Human Molecular Genetics
|
October 11, 2019
Acute manganese treatment restores defective autophagic cargo loading in Huntington's disease cell lines
Miles R Bryan, Michael T O'Brien, Kristen D Nordham, et al.
Sleep
|
November 11, 2020
A potential role for zinc in restless legs syndrome
Pan Chen, Julia Bornhorst, Stephanie Patton, et al.
Neurochemistry International
|
January 24, 2020
The effects of manganese overexposure on brain health
Mahfuzur R Miah, Omamuyovwi M Ijomone, Comfort O A Okoh, et al.
Aging and Disease
|
June 23, 2016
Linear and Curvilinear Trajectories of Cortical Loss with Advancing Age and Disease Duration in Parkinson's Disease
Daniel O Claassen, David G Dobolyi, David A Isaacs, et al.
Biomaterials
|
July 24, 2015
Combinatorial polymer matrices enhance in vitro maturation of human induced pluripotent stem cell-derived cardiomyocytes
Young Wook Chun, Daniel A Balikov, Tromondae K Feaster, et al.
Sensors and Actuators. B, Chemical
|
June 7, 2021
A bistable, multiport valve enables microformulators creating microclinical analyzers that reveal aberrant glutamate metabolism in astrocytes derived from a tuberous sclerosis patient
Dusty R Miller, David K Schaffer, M Diana Neely, et al.
Metallomics : Integrated Biometal Science
|
May 19, 2020
Huntington's disease genotype suppresses global manganese-responsive processes in pre-manifest and manifest YAC128 mice
Anna C Pfalzer, Jordyn M Wilcox, Simona G Codreanu, et al.
Journal of Huntington'S Disease
|
September 4, 2015
Novel BAC Mouse Model of Huntington's Disease with 225 CAG Repeats Exhibits an Early Widespread and Stable Degenerative Phenotype
Michal Wegrzynowicz, Terry Jo Bichell, Barbara D Soares, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
September 18, 2022
Treatment with THI, an inhibitor of sphingosine-1-phosphate lyase, modulates glycosphingolipid metabolism and results therapeutically effective in experimental models of Huntington's disease
Giuseppe Pepe, Luca Capocci, Federico Marracino, et al.
Scientific Reports
|
May 26, 2018
Author Correction: Defective Sphingosine-1-phosphate metabolism is a druggable target in Huntington's disease
Alba Di Pardo, Enrico Amico, Abdul Basit, et al.
Page
of 33